Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells (2023)
- Authors:
- USP affiliated authors: COLQUHOUN, ALISON - ICB ; SILVA, DENISE DE OLIVEIRA - IQ ; FORNACIARI, BÁRBARA - IQ ; ALVES, SAMARA RODRIGUES - IQ
- Unidades: ICB; IQ
- DOI: 10.1080/02652048.2023.2258967
- Subjects: NANOPARTÍCULAS; GLIOMA; ANTINEOPLÁSICOS; QUITOSANA; BIOPOLÍMEROS; FLUORESCÊNCIA; MICROSCOPIA DE FORÇA ATÔMICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Microencapsulation
- ISSN: 0265-2048
- Volume/Número/Paginação/Ano: v. 40, n. 7, p. 549-565, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
REHMAN, Hanif Ur et al. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells. Journal of Microencapsulation, v. 40, n. 7, p. 549-565, 2023Tradução . . Disponível em: https://doi.org/10.1080/02652048.2023.2258967. Acesso em: 21 maio 2024. -
APA
Rehman, H. U., Fornaciari, B., Alves, S. R., Colquhoun, A., & Silva, D. de O. (2023). Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells. Journal of Microencapsulation, 40( 7), 549-565. doi:10.1080/02652048.2023.2258967 -
NLM
Rehman HU, Fornaciari B, Alves SR, Colquhoun A, Silva D de O. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells [Internet]. Journal of Microencapsulation. 2023 ; 40( 7): 549-565.[citado 2024 maio 21 ] Available from: https://doi.org/10.1080/02652048.2023.2258967 -
Vancouver
Rehman HU, Fornaciari B, Alves SR, Colquhoun A, Silva D de O. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells [Internet]. Journal of Microencapsulation. 2023 ; 40( 7): 549-565.[citado 2024 maio 21 ] Available from: https://doi.org/10.1080/02652048.2023.2258967 - Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells
- A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties
- The novel ruthenium—γ-linolenic complex [Ru2(aGLA)4Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen on the mRNA expression of proteins involved in cell cycle control, angiogenesis and invasion in C6 rat glioma cells in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (nsaid) ibuprofen on the mRNA expression of proteins involved in cell cycle control, Angiogenesis and Invasion in C6 rat glioma cells in vitro
- Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs
- Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line
- Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo
- Diruthenium(II,III)-non-steroidal anti-inflammatory drug complexes and their effects on tumor-cell proliferation
- Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs)
Informações sobre o DOI: 10.1080/02652048.2023.2258967 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3158231.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
